Business Wire

HAI-ROBOTICS

23.5.2022 10:44:09 CEST | Business Wire | Press release

Share
HAI ROBOTICS to Show Its Tallest Robot for the 1st Time in Europe at LogiMAT 2022

HAI ROBOTICS, the pioneer in Autonomous Case-handling Robot (ACR) systems for warehouse logistics, will exhibit its cutting-edge automation technology at LogiMAT 2022, Europe's biggest annual intralogistics tradeshow, from May 31 to June 2 in Stuttgart, Germany.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220522005089/en/

The company will show how the ACR systems, a highly flexible goods-to-person solution that improves operation efficiency and storage density, could meet the current needs of Europe's warehouses and distribution centers.

The live demo at Booth D71, Hall 3 will be led by HAIPICK A42T, the tallest robot in HAI ROBOTICS' ACR systems that can reach a max picking height of 10-meters. Featuring a telescopic lift, the robot can also descend to as low as 0.28m to pick totes and cartons stored on the bottom level of the shelf. It can carry 8 loads to feed HAIPORT, goods-to-person workstation, in one move. The robot has been titled the "Best in Intralogistics" in IFOY 2021.

HAIPORT, also to be displayed at LogiMAT, is another warehousing efficiency and throughput booster. With the ability to load four to eight cases in only three seconds from a robot, and unload the same number of cases in five seconds at the same time, a single workstation is able to handle up to 900 cases per hour, an order-fulfillment speed that is 16 times faster than robot-to-conveyor belt transport.

ACR systems, "much more attractive"

HAI ROBOTICS sees the ACR systems a good fit for European users, especially in the age of e-commerce when more consumers are longing for faster deliveries and omni-channel shopping experience.

Mr Kai Ramadhin, the company's VP of Sales & Marketing Europe, said: "HAI ROBOTICS solution provides more flexibility in terms of expansion ability, rapid deployment times and so on. So the sweet-spot of our solution is much more attractive."

Mr Ramadhin noted the company is focused on creating a local network of system integrator, installation and service partners, so that any user of ACR systems can expect rapid and high-quality service wherever they are in Europe.

Since setting up its regional headquarters in the Netherlands in late 2021, HAI ROBOTICS has built a strong localized network in countries of France, Germany, Spain, Italy, the Benelux and the U.K.

The ACR systems are presented by its global partner Savoye at Log!Ville in Belgium in an initiative to make the high-density warehousing technology widely known to the European supply chain. The company has also teamed up with U.K.-based Invar System and Greece's Voyatzoglou Systems to enable tailored service accessible to regional business operators.

When the market gets increasingly dynamic and volatile, the company sees the systems can bring users some key benefits, including:

1. Alleviating labor challenges

Through the automation of practices, warehouses can meet the demands of the modern world by improving employee productivity and filling job vacancies, when recruiting and retaining gets tough.

Robots also free workers from doing repetitive and labour intensive work in the warehouse. The ACR systems, for example, save a worker 40,000 to 60,000 steps of walking per day, on average, according to the company's statistics.

2. Storage space utilization to save land investment

As warehouse ceiling heights have continuously risen, the ACR systems, with the max picking height reaching 10 meters, allow the warehouse to easily use the upper storage space. That may also save the user investment in warehouse expansion, in particular in countries where land costs are high.

3. Fast & flexible implementation, more affordable

Business owners are facing a fast-changing and less predictable market nowadays than ever before. The growing customer expectations for faster deliveries and omni-channel shopping experience are driving companies to rethink their supply-chain operating models. The ACR systems have the high level of flexibility to allow a project to be deployed within months, and can be easily scaled according to business volume. A warehouse owner can choose to scale operation by adding or removing robots without disrupting any ongoing operations since the ACR systems require no structural changes to an existing facility.

That also means the systems are more affordable, especially for smaller businesses.

In Europe, many small-to-medium-sized enterprises see a need for automation, but their limited budget does not allow them to spend years implementing large projects. The ACRs turn out to be a fit in that case too.

ACR systems allow any business to start automation small, and grow as business grows. Many of its subscribers started to customize their solutions with a few robots and adding more when their demand expands.

4. Ideal for the age of e-commerce

In the age of e-commerce, businesses across the globe need to deal with flurries of online orders, which often come scattered and in large numbers. Plus the need to shorten delivery time to improve customer satisfaction, they need to significantly boost the order-fulfilment speed of their warehouses and DCs.

E-grocery emerges to be the channel embracing the growth capabilities. According to McKinsey, e-grocery channel grew by more than 50 percent in 2020 - compared to 2019 growth - for key European markets, creating an even stronger need for efficient e-grocery fulfillment solutions. Smaller unit picks, mixed orders, and a high speed of delivery make e-grocery labor intensive and therefore ideal for automation.

The ACR systems can boost order-fulfillment efficiency when handling large SKU portfolio as well as small orders with a high share of single-unit picks in e-grocery warehouses.

In several micro-fulfillment centers in Europe, the ACR systems have been implemented to handle home-delivery orders as well as click-and-collect orders with contactless deliveries over the counter at the storefront.

ABOUT HAI ROBOTICS

HAI ROBOTICS, the pioneer in Autonomous Case-handling Robot (ACR) systems, is committed to providing efficient, intelligent, flexible, and customized warehouse automation solutions through robotics technology and AI algorithms. It aims to create value for each factory and logistics warehouse. The HAIPICK ACR system, independently developed in 2015, is the world's first of its kind.

Founded in 2016 in Shenzhen, China, HAI ROBOTICS has offices in the U.S., Europe, Japan, Southeast Asia, Australia, Hong Kong and Taiwan, serving customers from more than 30 countries and regions.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye